Bargeton B , Iwaszkiewicz J , Bonifacio G , Roy S , Zoete V , Kellenberger S .

P41 GM103311 NIGMS NIH HHS

	Figure 1. Docking of FRRFa peptide to the acidic pocket of the desensitized and closed conformation of ASIC1a. The human ASIC1a structural model is based for (a–c) on a desensitized chicken ASIC1 structure18, and for (d–g) on the closed chicken ASIC120. (a) General view of the channel, highlighting the location of cavities into which peptides may bind. The central vestibule, which is enclosed by the lower palm domain, is not indicated. Estimated volumes in the desensitized ASIC1a model are ∼1600 Å3 (acidic pocket), ∼1150 Å3 (thumb base pocket) and ∼1400 Å3 (central vestibule, CASTp30). (b) Single subunit with structural domains indicated: transmembrane part (red), palm (yellow), β-ball (orange), knuckle (cyan), finger (purple) and thumb (blue). (c) Example of a predicted FRRFa interaction mode with the ASIC1a acidic pocket of the desensitized state, shown in a structural view. (d,e) One of two predicted FRRFa interaction modes with the acidic pocket of closed ASIC1a, shown in a structural view (d) and a schematic 2D representation (e) that illustrates the interactions between peptide and channel (PoseView42). The colours in the scheme generated by PoseView were adjusted – the peptide is coloured as in (d and f) and the hydrophobic interactions are presented in purple. The program PoseView does not apply exactly the same stringency in the detection of H-bonds as Chimera41, therefore there exist some differences in the H-bond attribution. (f,g) Example of the second predicted FRRFa interaction mode with ASIC1a in the closed conformation, in structural view (f) and schematic 2D representation (g). In (c,d and f) the different domains of ASIC subunits are coloured as in (b) for the subunit on the left, while the second subunit is shown in red. The peptide is shown in green, with light green at the N-terminus and dark green at the C-terminus; the heteroatoms of highlighted residues are colored in blue (nitrogen), red (oxygen) and white (hydrogen). Letters at the end of residue identifiers in (e and g) indicate the ASIC subunit (A, B or C). Residues that were mutated for the functional analysis are presented in ball and stick representation and labelled in bold.
	Figure 2. FRRFa modulation of ASIC1a currents is only partially affected by acidic pocket mutations. (a) FRRFa concentration-response curve. Top, representative current traces. Bottom, Isust/Ipeak ratio induced by pH5 as a function of the FRRFa concentration (pre-applied during 45–50 s and present in pH5 solution), n = 7–11. (b) Time course of disappearance of the FRRFa-induced Isust. FRRFa at 50 μM was applied for 45 s, and current was measured once every minute during washout with FRRFa-free solution. Exponential fit shown as solid line (n = 4, error bars are smaller than the symbols). (c) Time course of appearance of Isust. Oocytes were exposed for various durations to 50 μM FRRFa in the pH7.4 conditioning solution, before activation of ASIC currents with pH5, including 50 μM FRRFa. Exponential fit shown as solid line, n = 4. (d–f) and (i–k), all Cys mutants had been exposed during 3 min to 1 mM MTSET before the experiment. (d) Bar graph of the Isust/Ipeak ratio induced by pH5. Grey bars, control; red bars, after exposure to 50 μM FRRFa, n = 4–40. *p < 0.05, **p < 0.01, different from the same condition in WT; ###p < 0.001, ####p < 0.0001, the FRRFa-induced increase in Isust/Ipeak (see e,f) is different from this ratio in WT. (e) ratio of FRRFa-induced Isust/Ipeak increase by 50 μM FRRFa (n = 4–40). (f) ratio of FRRFa-induced Isust/Ipeak increase by 500 μM FRRFa (n = 5–11). (g) Representative current traces of WT ASIC1a obtained at the indicated pH conditions, without FRRFa (top), with 15 μM FRRFa in the conditioning solution (bottom). (h) pH dependence of steady-state desensitization (SSD). Normalized pH5-induced current amplitude plotted against the conditioning pH (n = 8). The lines represent fits to the Hill equation described in Methods, pH protocol illustrated in inset. FRRFa was administered during the conditioning period (55 s). (i) Midpoint of SSD curve (pHD50) values obtained in the absence of FRRFa (n = 4–12). *p < 0.05; ****p < 0.0001; different from WT. (j) Difference in pHD50 (pHD50FRRFa-pHD50ctrl), n = 4–12. (k) nHFRRFa/nHctrl ratio. The pHD50 shifts and nH ratios of mutant channels were not different from those of WT.
	Figure 3. Docking results of FRRFa peptide to the thumb base pocket of the desensitized and the closed conformation of ASIC1a. The human ASIC1a structural model is based for (a) on a desensitized ASIC1 structure18, and for (b,c) on the closed ASIC1a structure20. (a) Predicted FRRFa interaction mode with the desensitized ASIC1a thumb base pocket. (b,c) Predicted FRRFa interaction mode with the closed ASIC1a thumb base pocket in structural view (b) and schematic 2D representation (c). The color code is as described in the legend to Fig. 1. Residues that were mutated for the functional analysis are shown in ball and stick representation in panels a and b and labelled in bold in all three panels.
	Figure 4. Thumb base mutations do not prevent FRRFa modulation of ASIC1a currents. (a) Bar graph of the Isust/Ipeak ratio induced by pH5 of WT and thumb base mutants as indicated; grey bars, control; red bars, 50 μM FRRFa, n = 4–22. (b) Ratio of FRRFa-induced increase in Isust/Ipeak in the indicated mutants (n = 4–22). For (a–d) **p < 0.01, ****p < 0.0001, different from the same condition in WT; #p < 0.05, ##p < 0.01, the FRRFa-induced increase in Isust/Ipeak is different from this ratio in WT. (c) Bar graph of the Isust/Ipeak ratio induced by pH5 of WT F302C-MT. (d) Ratio of FRRFa-induced increase in Isust/Ipeak in the indicated mutants. For (c,d) the oocytes had been exposed during 3 min to 1 mM MTSMT (n = 5) prior to the experiment. (e) Representative current traces of ASIC1a-F302A in the absence and presence of 100 μM FRRFa. (f) FRRFa concentration-response curve of the Isust/Ipeak current ratio induced by pH5 in oocytes expressing F302A, n = 8. The WT curve is shown for comparison (n = 7–11). (g) Time course of disappearance of the FRRFa-induced sustained current in the F302A mutant and WT. FRRFa at 50 μM was applied for 45 s, and then washed out. The normalized Isust/Ipeak ratio is plotted as a function of time. Exponential fit shown as solid line, n = 9 (F302A) and n = 4 (WT).
	Figure 5. Docking results of FRRFa peptide to the central vestibule of the open and closed conformation of ASIC1a. The structural images are for (a,b) from a human ASIC1a model based on the Mit-toxin-opened ASIC1 structure29, and for (c–f) from a model of the closed state20. (a) Predicted FRRFa interaction mode with the central vestibule of the open ASIC1a. (b) Predicted FRRFa interaction mode with a side cavity of the central vestibule of the open ASIC1a. Note that the N terminus is located inside the central vestibule. (c–f) Two predicted FRRFa poses in a side cavity of the central vestibule of closed ASIC1a, in structural view (c,e) and schematic 2D representation (PoseView, modified as in Fig. 1, d,f). (e,f) For this pose, the Chimera software detected additional interactions, not detected by PoseView: a hydrogen bond between Arg3 and the Thr370 backbone and a hydrogen bond between Phe1 backbone and the Asn416 side chain. The colour code of the peptide is the same as described in the legend of Fig. 1. The three ASIC subunits are colored in yellow, red, and blue. Residues that were mutated for the functional analysis are are shown in ball and stick representation in panels a, b, c and e and labelled in bold in all panels.
	Figure 6. Mutations of the palm change FRRFa modulation of ASIC1a. Mutants containing “-ET” in their name had been exposed during 3 min to 1 mM MTSET prior to the experiment. (a) Representative current traces of the mutant E418C in the absence and presence of 50 μM FRRFa. (b) Bar graph of the Isust/Ipeak ratio induced by pH5 of WT and mutants as indicated (n = 5–41). For (b,g–i) *p < 0.05; **p < 0.01, ***p < 0.001, ****p < 0.0001, different from WT. (c) Ratio of 50 μM FRRFa-induced increase in Isust/Ipeak (n = 5–41). (d) Ratio of 500 μM FRRFa-induced increase in Isust/Ipeak (n = 5–11). For (b–d) #p < 0.05; ##p < 0.01; ###p < 0.001; ####p < 0.0001; ratio different from the ratio in WT. (e) FRRFa concentration-response curve of the Isust/Ipeak current ratio induced by pH5 in oocytes expressing N416C, n = 8. The WT curve is shown for comparison (n = 7–11). (f) Time course of disappearance of the FRRFa-induced sustained current in the N416C mutant and in WT. 50 μM FRRFa was applied for 45 s, and then washed out. The normalized Isust/Ipeak ratio is plotted as a function of time, and the solid line represents an exponential fit to the data, n = 9 (N416C) and n = 4 (WT). (g) pHD50 values obtained in the absence of FRRFa (n = 5–54). (h) The difference in pHD50 (pHD50FRRFa-pHD50ctrl) is plotted in the bar graph, n = 5–54. (i) Plot of the ratio nHFRRFa/nHctrl of the SSD pH dependence.

Askwith, Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. 2000, Pubmed, Xenbase

Askwith, Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. 2000, Pubmed , Xenbase
Assmann, The comprehensive analysis of DEG/ENaC subunits in Hydra reveals a large variety of peptide-gated channels, potentially involved in neuromuscular transmission. 2014, Pubmed , Xenbase
Baconguis, Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes. 2012, Pubmed
Baconguis, X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na(+)-selective channel. 2014, Pubmed
Bargeton, The contact region between three domains of the extracellular loop of ASIC1a is critical for channel function. 2010, Pubmed , Xenbase
Boscardin, The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19. 2016, Pubmed
Brussaard, Peripheral injection of DNS-RFa, a FMRFa agonist, suppresses morphine-induced analgesia in rats. 1989, Pubmed
Chen, The tarantula toxin psalmotoxin 1 inhibits acid-sensing ion channel (ASIC) 1a by increasing its apparent H+ affinity. 2005, Pubmed , Xenbase
Chen, Interaction of acid-sensing ion channel (ASIC) 1 with the tarantula toxin psalmotoxin 1 is state dependent. 2006, Pubmed , Xenbase
Cristofori-Armstrong, Acid-sensing ion channel (ASIC) structure and function: Insights from spider, snake and sea anemone venoms. 2017, Pubmed
Dawson, Structure of the acid-sensing ion channel 1 in complex with the gating modifier Psalmotoxin 1. 2012, Pubmed
Della Vecchia, Gating transitions in the palm domain of ASIC1a. 2013, Pubmed , Xenbase
Dundas, CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. 2006, Pubmed
Frey, Conformational changes in the lower palm domain of ASIC1a contribute to desensitization and RFamide modulation. 2013, Pubmed , Xenbase
García-Añoveros, BNaC1 and BNaC2 constitute a new family of human neuronal sodium channels related to degenerins and epithelial sodium channels. 1997, Pubmed
Golubovic, A peptide-gated ion channel from the freshwater polyp Hydra. 2007, Pubmed
Gonzales, Pore architecture and ion sites in acid-sensing ion channels and P2X receptors. 2009, Pubmed
Gründer, Peptide-gated ion channels and the simple nervous system of Hydra. 2015, Pubmed
Jasti, Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. 2007, Pubmed
Kellenberger, International Union of Basic and Clinical Pharmacology. XCI. structure, function, and pharmacology of acid-sensing ion channels and the epithelial Na+ channel. 2015, Pubmed
Krauson, Independent contribution of extracellular proton binding sites to ASIC1a activation. 2013, Pubmed , Xenbase
Liechti, A combined computational and functional approach identifies new residues involved in pH-dependent gating of ASIC1a. 2010, Pubmed
Lingueglia, FMRFamide-gated sodium channel and ASIC channels: a new class of ionotropic receptors for FMRFamide and related peptides. 2006, Pubmed
Ostrovskaya, Modulatory action of RFamide-related peptides on acid-sensing ionic channels is pH dependent: the role of arginine. 2004, Pubmed
Parhar, RFamide peptides as mediators in environmental control of GnRH neurons. 2012, Pubmed
Paukert, Candidate amino acids involved in H+ gating of acid-sensing ion channel 1a. 2008, Pubmed , Xenbase
Pettersen, UCSF Chimera--a visualization system for exploratory research and analysis. 2004, Pubmed
Reimers, Identification of a cono-RFamide from the venom of Conus textile that targets ASIC3 and enhances muscle pain. 2017, Pubmed , Xenbase
Reiners, The Conorfamide RPRFa Stabilizes the Open Conformation of Acid-Sensing Ion Channel 3 via the Nonproton Ligand-Sensing Domain. 2018, Pubmed , Xenbase
Roy, Molecular determinants of desensitization in an ENaC/degenerin channel. 2013, Pubmed
Saez, Molecular dynamics and functional studies define a hot spot of crystal contacts essential for PcTx1 inhibition of acid-sensing ion channel 1a. 2015, Pubmed , Xenbase
Sherwood, Endogenous arginine-phenylalanine-amide-related peptides alter steady-state desensitization of ASIC1a. 2008, Pubmed , Xenbase
Sherwood, Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death. 2009, Pubmed , Xenbase
Sluka, The dichotomized role for acid sensing ion channels in musculoskeletal pain and inflammation. 2015, Pubmed
Stauffer, Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. 1994, Pubmed
Stierand, Molecular complexes at a glance: automated generation of two-dimensional complex diagrams. 2006, Pubmed
Trott, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. 2010, Pubmed
Vick, ASICs and neuropeptides. 2015, Pubmed
Vullo, Conformational dynamics and role of the acidic pocket in ASIC pH-dependent gating. 2017, Pubmed
Wemmie, Acid-sensing ion channels in pain and disease. 2013, Pubmed
Xiong, Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. 2004, Pubmed
Yang, Ion conduction and selectivity in acid-sensing ion channel 1. 2014, Pubmed , Xenbase
Yoder, Gating mechanisms of acid-sensing ion channels. 2018, Pubmed